Medical Mycology

Papers
(The H4-Index of Medical Mycology is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Development of in-house ELISA for Scedosporium/Lomentospora serodiagnosis37
OUP accepted manuscript33
Inhibitory effect of polyunsaturated fatty acids alone or in combination with fluconazole on Candida krusei biofilms in vitro and in Caenorhabditis elegans30
S2.2d Evaluation of new tools for the diagnosis of histoplasmosis28
A 40-year antifungal susceptibility surveillance of Talaromyces marneffei (1984–2024) at a tertiary hospital in Guangxi, China28
S6.5c MycetOS: identifying drugs which can penetrate the mycetoma grain28
S7.2d Divergent EGFR/MAPK-mediated immune responses to clinical Candida pathogens in vulvovaginal candidiasis27
Investigation of CryptoPS LFA-positive sera in patients at risk of cryptococcosis26
S1.3c Diversity and hybridization in Malassezia furfur26
Superficial fungal infections in the south of France—is fusariosis the next emergent onychopathy?23
A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole22
S5.1b Antifungal r esistance22
Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants21
P422 EQUAL PCP Score 2022—an ECMM score derived from current guidelines to measure QUAlity of clinical Pneumocystis Pneumonia management20
P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study20
Knowledge and regulation on fungal contamination of sand and water: Progress report and perspectives20
P373 Does biofilm forming capacity of Candida tropicalis vary with echinocandin susceptibility?19
The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo19
P049 Candidemia: Isolate profiling and antifungal susceptibility testing experience from Jodhpur, Western India19
0.27856802940369